By Christopher Snowbeck From Star Tribune MINNEAPOLIS—A subset of COVID-19 patients who received infusions of laboratory-made antibodies ran a lower risk of requiring hospital care for their illnesses, according to a Mayo Clinic study released Monday. The report in the journal Lancet EClinical Medicine suggests that certain monoclonal antibody treatments can help patients with mild

Leave a Reply